Medtronic PLC (NYSE:MDT)

85.25
Delayed Data
As of 4:00pm ET
 0.00 / 0.00%
Today’s Change
75.77
Today|||52-Week Range
114.31
+9.69%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$116.5B

Company Description

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Contact Information

Medtronic Plc
20 On Hatch
Dublin Dublin 2
P:(531) 438-1700
Investor Relations:
(763) 505-4626

Employees

Shareholders

Mutual fund holders47.48%
Other institutional36.77%
Individual stakeholders0.18%

Top Executives

Geoffrey Straub MarthaChairman & Chief Executive Officer
Megan Fulton RiddleVice President
Gregory L. SmithExecutive VP-Global Operations & Supply Chain
Karen L. ParkhillChief Financial Officer & Executive Vice President
Laura MauriCSO, Chief Medical & Regulatory Officer, Senior VP